Insulet
PODD
#1438
Rank
NZ$25.71 B
Marketcap
NZ$365.27
Share price
0.88%
Change (1 day)
-20.52%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): NZ$0.68 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.70 Billion. , an increase over its 2024 earnings that were of NZ$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.69 B16.27%
2024 NZ$0.59 B36.76%
2023 NZ$0.43 B481.9%
2022 NZ$75.02 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$95.56 M18.51%
2019 NZ$80.64 M41.16%
2018 NZ$57.12 M-711.95%
2017 -NZ$9.34 Million-56.85%
2016 -NZ$21.64 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$63.84 Million31.04%
2013 -NZ$48.72 Million-21.96%
2012 -NZ$62.43 Million
2010 -NZ$59.54 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$93.73 Million209.75%
2006 -NZ$30.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.40 B 8,313.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.73 B 2,022.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.92 B 1,473.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$44.79 B 6,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.36 Billion-151.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.17 B-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$1.92 B 177.51%๐Ÿ‡บ๐Ÿ‡ธ USA